Genzyme Warned Over Procedures At Drug Plant
The U.S. Food and Drug Administration has threatened to withhold approval of Genzyme Corp.'s drug shipments and to delay approval of its drug Lumizyme, a treatment for Pompe disease, after inspections...To view the full article, register now.
Already a subscriber? Click here to view full article